ESOPHAGEAL CANCER. Epidemiology 3/22/2017. Esophageal Carcinoma: subtypes. Esophageal Adenocarcinoma (EAC) Epidemiology.

Size: px
Start display at page:

Download "ESOPHAGEAL CANCER. Epidemiology 3/22/2017. Esophageal Carcinoma: subtypes. Esophageal Adenocarcinoma (EAC) Epidemiology."

Transcription

1 ESOPHAGEAL CANCER Disclosures Sushil Ahlawat, MD, FACP, FASGE, AGAF Associate Professor of Medicine Director of Endoscopy RUTGERS NJMS Nothing to disclose. Esophageal Carcinoma: subtypes Subtype Squamous cell carcinoma (SCC) Adenocarcinoma (EAC) Geographic distribution Asia, Africa, South America, African American in North America North America, Europe Risk factors Alcohol, tobacco GERD, Obesity Precursor lesion Esophageal squamous dysplasia Barrett s esophagus Esophageal Adenocarcinoma (EAC) Epidemiology Risk factors Staging and therapy Early stage disease & endoscopic therapy Prognoses Future developments Epidemiology In 2014,18,000 new cases of esophageal ca, 60% of which were EAC The incidence of EAC in the US was 2.5 per 100,000 people in 2011 The incidence of EAC has continued to increase in the US but may be reaching a plateau Trend of incidence of EAC in US SEER Cancer Registry SEER cancer registry, US 1

2 Risk factors of EAC Male sex Advancing age White race GERD Obesity Tobacco use Barrett s esophagus Risk Factors of EAC Risk of EAC is 8-fold greater in patients with recurrent GERD symptoms Patients with long standing symptoms, nocturnal symptoms, or more frequent symptoms are at increased risk Severity of symptoms is not associated with increased risk of EAC GERD erosive esophagitis aberrant healing process BE (0.12% to 0.60% per year) EAC Approximately 50-60% patients with EAC do not have GERD Rubenstein JH, Shaheen N. Gastroenterology 2015:149:302. Shaheen N, Ransohoff DF. JAMA 2002; 287: Tramacere I, et al.epidemiology 2011; 22: Risk Factors of EAC Obesity increases risk by x2.4 to 2.8 Abdominal obesity increases risk of BE & EAC Mechanical effect of obesity hiatal hernia increased risk of GERD Hormonal effects of obesity (IGF) alterations of adipokines BE EAC Risk factors of EAC Infection with H pylori appears to protect against EAC EAC risk is reduced in population with H pylori prevalence; meta-analysis of 15 studies showed EAC risk decreased by 41% among those with H pylori However, HPE neither cause or worsens GERD Singh S, et al. Clin Gastroenterol Hepatol 2013; 11: Fischbach LA, et al. Am J Gastroenterol2014; 109: Malfertheiner P,et al. Gut 2012; 61: Risk factors of EAC Alcohol is not risk factor for EAC but risk of SCC is x3 to x5 among those taking 3 or > drinks/day Tobacco use increased the risk of EAC by 2.18 fold High intake of red meats, fats, processed foods increase risk High intake of fiber, fresh fruits, and vegetables lowers the risk Statins, aspirin, NSAIDs lower risk Endoscopic screening & surveillance (EAC) BE is precursor of EAC 6-12% of patient with long standing GERD have BE on endoscopic screening 40% patients with BE do not have GERD Annual cancer risk of EAC is 0.12 to 0.40% in non-dysplastic BE Dysplasia in BE signals increased risk: 1% for LGD and >5% for HGD Tramacere I, et al. Ann Oncol 2012; 23: Kubo A, et al. Nutr Res Rev 2010; 23: Hvid-Jensen F, et al. N Engl J Med 2011; 365: de Jonge PJ, et al Gut 2010;59: Dulai GS, et al. Gastroenterology 2002; 122:

3 Endoscopic screening and surveillance Endoscopic surveillance every 3 years is recommended for non-dysplastic BE percent EAC diagnosed in patient with no BE EAC detected during endoscopic surveillance for BE is more likely to be early stage, amenable to curative therapy & survival is longer compared to those with symptoms in whom EAC is diagnosed Clinical presentation Progressive dysphagia, weight loss, refractory GERD, GIB Less common symptoms: Fe def anemia, oropharyngeal dysphagia Asymptomatic: discovered during screening or surveillance endoscopy (<15% cases of EAC) Only 25% of patients with EAC present with localized disease Spechler SJ, et al.gastroenterology 2011; 140(3): e18-e52. Cooper GS, et al. Am J Gastroenterol 2009;104: Diagnosis CT doesn t accurately identify localized EAC Barium esophagogram Endoscopy: diagnosis and plan of therapy Stricture, mass, ulcer, nodule, subtle irregularity in the mucosa Size, location and morphology EAC occur in distal esophagus or GE junction in 75% of patients Rubenstein JH, Shaheen N. Gastroenterology 2015:149:302. 3

4 Staging and LN metastasis Management: Staging Endoscopy with or without mucosal resection (EMR) CT chest/abdomen Endoscopic ultrasound (EUS) PET scan Holscher AH, et al. Ann Surg 2011;254:802. N Engl J Med 2014;371: Role of EUS in staging Highly accurate for T, N staging Not reliable for T1a vs T1b endoscopic appearance size, diameter, failure to rise with submucosal injection, multifocality, mucosectomy/large biopsy Lymph node >10 mm, round, smooth, hypoechoic Accuracy 80; FNA increases accuracy to 92-98% Restaging after chemo-radiation EUS accuracy for T (30-60%), N (40-70%) PET /CT better accuracy than EUS Qumaeya B, et al. GIE 2015;81:865 Management: Mucosal Tumors (Stage 0 or 1a) Stage 0 or 1a: HGD or EAC limited to the mucosa Risk of LN metastasis is 0 Esophagectomy Endoscopic therapy Visible lesions, <2 cm in size Small resectable areas of dysplastic BE Moderate or well differentiated grade EAC Lack of lymphovascular invasion Gastroenterology 2011;141:42 Rubenstein JH, Shaheen N. Gastroenterology 2015:149:302. Pech O, et al. Gastroenterology 2014;146:652. 4

5 Endoscopic therapy Endoscopic resection EMR, ESD Provides histologic data: depth of invasion, grade, LVI Staging and treatment Endoscopic ablation RFA, Cryoablation, Argon, PDT Doesn t provide histologic data Buried glands Hybrid (resection+ ablation) Endoscopic therapy Endoscopic eradication of residual BE 30% recurrence of EAC without adjuvant BE eradication Stepwise radical endoscopic resection of residual BE High rate of stricture formation compared to ablation therapy Most reported modality is RFA 80% success in complete remission of dysplasia in patients with T1a EAC Recurrence of BE in 33% within 2 years after complete eradication of BE (cohort without cancer at baseline) Aggressive surveillance is recommended: q 3 months for 1 year, q 6 months during 2 nd year, and annually thereafter Haidry RJ, et al. Gastroenterology 2013;145:87 Gupta M, et al. Gastroenterology 2013;145:79. Pech O, et al. Gastroenterology 2014;146:652 Van Vilsteren FG, et al. Gut 2011;60:765.. Rustgi AK, El-Serag HB. N Engl J Med 2014;371: Management: Mucosal Tumors Stage 1b Stage 1b : tumors that have penetrated muscular mucosae and have invaded submucosa sm1, sm2, sm3 Risk of LN metastasis is up to 13-56% ESD for selected sm1/sm2 (<2 cm, no lymphovascular invasion, <500mmicton invasion) Radical esophagectomy Holscher AH, et al. Ann Surg 2011;254:802. Rubenstein JH, Shaheen N. Gastroenterology 2015:149:302. 5

6 Management: locally advanced tumors Stage IIA:T 2 N 0 M 0 Stage IIB:T 3 N 0 M 0 ; T 1-2 N 1 M 0 Neo-adjuvant CRT Esophagectomy Surgical outcome better in highvolume centers Minimally invasive esophagectomy may have similar outcomes but is technically challenging Overall 3-year survival is % Poor outcome in residual, node +, completely resected disease adjuvant CRT benefits SCC,?EAC Wouters MW, et al. Cancer 2012;118:1754 Stage III:T 4 N 0 M 0, T 3 N 1 M 0, T 1-2 N 2 M 0 Stage IV:T any N any M 1 Management: Advanced Tumors 5 yr survival is <15% Endoscopic placement of SEMS High dose intraluminal brachytherapy Endosocpic dilation or ablation, placement of plastic stents, bypass surgery or chemoradiotherapy are NOT recommended Low efficacy & high complications Palliative chemotherapy Unresectable, metastatic, recurrent disease Sreedharan A, et al. Cochrane Database Syst Rev 2009; 4: CD Zhu HD, et al. Lancet Oncol 2014; 15: Types Self-expanding metal (nitinol) stents (SEMS) Fully covered (FC) Do not have any exposed bare metal More prone to stent migration Partially covered (PC) Small portion of exposed bare metal at the proximal & distal ends to allow embedding into esophageal wall Less prone to stent migration Uncovered (UC) Original SEMS Tumor or granulation tissue ingrowth Palliative Treatment of Malignant Esophageal Stricture FC or PC SEMS equally effective & safe Stents with anti-reflux features may have decreased GER & complications Special features (niti-s) to reduce migration rate can cause traumatic injury & major adverse events Insufficient evidence to recommend one type of SEMS over other type SEPS conforms less easily to stricture, high complication rate including migrations, & increased failure rate of stent placement because of wider diameter of delivery system Didden P. Curr Gastroenterol Rep 2013;15:319 6

7 Palliative Treatment of Malignant Esophageal Fistula Fistula result from invasion of respiratory tract or pleural cavity, mediastinal or lung ca invasion of esophagus Closure rate % with covered SEMS FC or PC SEMS can be used as long as covering completely seals the fistula Treatment of choice for malignant fistula Shin JH. Radiology 2004;232:252 Stent Placement as a Bridge to Surgery Neo-adjuvant CRT used in regionally localized esophageal cancer Stent could serve as bridge to surgery during neoadjuvant CRT by maintaining nutrition Stent-related complications can be avoided by performing esophagectomy shortly after neo-adj CRT is completed Several studies reported benefit in improving dysphagia & maintaining nutrition; however, complications such as perforation, migration leading SB perforation & obstruction have been reported Stent Placement as a Bridge to Surgery Low curative resection rate reported in recent studies due to progression or discovery of metastatic disease Oncologic outcome including 3-year survival negatively impacted with stent placement Mechanism of negative oncologic outcomes SEMS expansive radial force causes peri-stent fibrosis compromising the normal plane of dissection SEMS fixating spur might cause micro-perforation disseminating tumor cells SEMS insertion increases level of circulating neoplastic cells CRT can accentuate stent-related complication such as fistula Inability to accurately restage tumor after stent insertion J Am Coll Surg 2015;220:287 Irradiation Stents SEMS loaded with I 125 combines the advantages of stents & brachytherapy into a single treatment modality Prolongs survival, sustained relief of dysphagia in advanced or non-resectable esophageal cancer No difference in complications compared to SEMS Non FDA device in Asian populations, no data from US Not recommended in US Stent- related Complications: Early Immediately or within 2-4 weeks Chest pain up to 60%, moderate to severe lasting 10 days, requiring analgesics in 90%, rarely need to remove stent Fever GERD mixed data on effectiveness of stent w/anti-relfux valve Globus sensation Perforation Stent migration 7-75% Bleeding: 1% Lancet 2014:15:546 7

8 Stent-related Complications: Delayed Recurrent dysphagia rate 53-65% requiring re-intervention in 50% Tumor over- or ingrowth: 2 nd stents restores luminal patency Migration in 7-75%:Endoscopic repositioning or exchange for new stent Food impaction: endoscopy Recurrence of stricture: 50% Spontaneous stent fracture & collapse endoscopic stent in stent technique Fistula formation Due to radial force causing pressure necrosis, next to proximal or distal margin, managed by covered stent Death: 0.5-2% Wang MQ et al. J Vasc Interv Radiol 2001;12:465 Homann N, et al. Dig Dis Sci 2008;53:334 Ramirez FC, et al. Gastrointest Endosc 1997;45:360 Prognosis The overall 5-year survival rate of EAC in US is17% Patients are diagnosed when regional (30%) or distant (40%) metastasis has already occurred 5-year survival for localized disease is 39% and 4% when distant metastasis is present 60-70% have not been receiving guidelines concordant therapy Management appear to improve by discussion with multidisciplinary tumor board Summary The main risk factors for EAC are GERD, obesity, cigarette smoking; cigarette smoking & alcohol consumption are main risk factors for SCC Endoscopic screening detects BE & periodic surveillance of BE detects dysplasia and early EAC Endoscopic hybrid therapy (EMR+RFA) is effective & safe for mucosal tumors Esophagectomy preceded by neoadjuvant CRT is the treatment of choice for localized tumors Endoscopic placement of SEMS is first line palliative options for dysphagia due to advanced or recurrent tumors 8

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI Barrett s Esophagus Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI A 58 year-old, obese white man has had heartburn for more than 20 years. He read a magazine

More information

Barrett s Esophagus: Old Dog, New Tricks

Barrett s Esophagus: Old Dog, New Tricks Barrett s Esophagus: Old Dog, New Tricks Stuart Jon Spechler, M.D. Chief, Division of Gastroenterology, VA North Texas Healthcare System; Co-Director, Esophageal Diseases Center, Professor of Medicine,

More information

AGA SECTION. Gastroenterology 2016;150:

AGA SECTION. Gastroenterology 2016;150: Gastroenterology 2016;150:1026 1030 April 2016 AGA Section 1027 Procedural intervention (3) Upper endoscopy indications 3 6 Non-response of symptoms to a 4 8 week empiric trial of twice-daily PPI Troublesome

More information

Barrett s Esophagus: Ablate Everyone?

Barrett s Esophagus: Ablate Everyone? Nicholas J. Shaheen, MD, MPH, FACG Barrett s Esophagus: Ablate Everyone? Nicholas J. Shaheen, MD, MPH, FACG Center for Esophageal Diseases and Swallowing University of North Carolina Greetings from UNC,

More information

Barrett s esophagus. Barrett s neoplasia treatment trends

Barrett s esophagus. Barrett s neoplasia treatment trends Options for endoscopic treatment of Barrett s esophagus Patrick S. Yachimski, MD MPH Director of Pancreatobiliary Endoscopy Assistant Professor of Medicine Division of Gastroenterology, Hepatology & Nutrition

More information

Faculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014

Faculty Disclosure. Objectives. State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) 24/11/2014 State of the Art #3: Referrals for Gastroscopy (focus on common esophagus problems) Dr. Amy Morse November 2014 Faculty: Amy Morse Faculty Disclosure Relationships with commercial interests: Grants/Research

More information

Learning Objectives:

Learning Objectives: Crescent City GI Update 2018 Ochsner Clinic, NOLA Optimizing Endoscopic Evaluation of Barrett s Esophagus What Should I Do in My Practice? Gregory G. Ginsberg, M.D. Professor of Medicine University of

More information

Stenting for Esophageal Cancer Technical Issues and Outcomes

Stenting for Esophageal Cancer Technical Issues and Outcomes Stenting for Esophageal Cancer Technical Issues and Outcomes Moishe Liberman Director C.E.T.O.C. Division of Thoracic Surgery Centre Hospitalier de l Université de Montréal Disclosures Research and Educational

More information

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management Barrett s Esophagus: Controversy and Management History Norman Barrett (1950) Chronic Peptic Ulcer of the Oesophagus and Oesophagitis Allison and Johnstone (1953) The Oesophagus Lined with Gastric Mucous

More information

Esophageal cancer: Biology, natural history, staging and therapeutic options

Esophageal cancer: Biology, natural history, staging and therapeutic options EGEUS 2nd Meeting Esophageal cancer: Biology, natural history, staging and therapeutic options Michael Bau Mortensen MD, Ph.D. Associate Professor of Surgery Centre for Surgical Ultrasound, Upper GI Section,

More information

Definition of GERD American College of Gastroenterology

Definition of GERD American College of Gastroenterology Definition of GERD American College of Gastroenterology GERD is defined as chronic symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus DeVault et al. Am J

More information

Ablation for Barrett s Esophagus: Burn or Freeze

Ablation for Barrett s Esophagus: Burn or Freeze Ablation for Barrett s Esophagus: Burn or Freeze John R. Saltzman MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School Disclosures No relevant disclosures

More information

Gregory G. Ginsberg, M.D.

Gregory G. Ginsberg, M.D. Radiofrequency Ablation for Barrett s Esophagus with HGD Gregory G. Ginsberg, M.D. Professor of Medicine University of Pennsylvania School of Medicine Abramson Cancer Center Gastroenterology Division Executive

More information

RFA and Cyrotherapy for Esophageal Disease

RFA and Cyrotherapy for Esophageal Disease RFA and Cyrotherapy for Esophageal Disease Daniel L. Miller MD Chief, General Thoracic Surgery WellStar Healthcare System/ Mayo Clinic Care Network Clinical Professor of Surgery Medical College of Georgia/

More information

Present Day Management of Barrett s Esophagus

Present Day Management of Barrett s Esophagus Slide 1 Present Day Management of Barrett s Esophagus Kinnari R. Kher, M.D. Slide 2 Goals Risk factors for development of Barrett s esophagus Risks for progression to Esophageal Adenocarcinoma Current

More information

Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD?

Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD? Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD? Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina 1 Outline What are the risks of progression

More information

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus

ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus ACG Clinical Guideline: Diagnosis and Management of Barrett s Esophagus Nicholas J. Shaheen, MD, MPH, FACG 1, Gary W. Falk, MD, MS, FACG 2, Prasad G. Iyer, MD, MSc, FACG 3 and Lauren Gerson, MD, MSc, FACG

More information

Management of Barrett s Esophagus. Case Presentation

Management of Barrett s Esophagus. Case Presentation Management of Barrett s Esophagus Lauren B. Gerson MD, MSc Associate Clinical Professor, UCSF Director of Clinical Research Gastroenterology Fellowship Program California Pacific Medical Center San Francisco,

More information

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery

Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery Joel A. Ricci, MD SUNY Downstate Medical Center Department of Surgery Norman Barrett (1950) described the esophagus as: that part of the foregut, distal to the cricopharyngeal sphincter, which is lined

More information

Current Management: Role of Radiofrequency Ablation

Current Management: Role of Radiofrequency Ablation Esophageal Adenocarcinoma And Barrett s Esophagus: Current Management: Role of Radiofrequency Ablation Ketan Kulkarni, MD Regional Gastroenterology Associates of Lancaster INTRODUCTION The prognosis of

More information

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus

New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus New Developments in the Endoscopic Diagnosis and Management of Barrett s Esophagus Prateek Sharma, MD Key Clinical Management Points: Endoscopic recognition of a columnar lined distal esophagus is crucial

More information

Management of Barrett s: From Imaging to Resection

Management of Barrett s: From Imaging to Resection Management of Barrett s: From Imaging to Resection Michael Wallace, MD, MPH, FACG Professor of Medicine Mayo Clinic Florida Goals of Endoscopic Evaluation in Barrett s Detect Barrett s and dysplasia Reduce/eliminate

More information

MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018

MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018 MANAGEMENT OF BARRETT S RELATED NEOPLASIA IN 2018 Sachin Wani Medical Director Esophageal and Gastric Center Division of Gastroenterology and Hepatology University of Colorado Anschutz Medical Campus DISCLOSURES

More information

National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia

National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia Patient Details Surname: NHS number: Forename: Postcode: Sex: Male Female

More information

Slide 1. Slide 2. Slide 3 Pancreatic Cancer- Case #1. Endoscopic management of GI malignancy. Endoscopic approaches in GI malignancy- Agenda

Slide 1. Slide 2. Slide 3 Pancreatic Cancer- Case #1. Endoscopic management of GI malignancy. Endoscopic approaches in GI malignancy- Agenda Slide 1 A teaching hospital of Harvard Medical School Endoscopic management of GI malignancy Tyler Berzin MD, MS Center for Advanced Endoscopy Division of Gastroenterology Beth Israel Deaconess Medical

More information

Is Radiofrequency Ablation Effective In Treating Barrett s Esophagus Patients with High-Grade Dysplasia?

Is Radiofrequency Ablation Effective In Treating Barrett s Esophagus Patients with High-Grade Dysplasia? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is Radiofrequency Ablation Effective

More information

Endoscopic UltraSound (EUS) Endoscopic Mucosal Resection (EMR) Moishe Liberman Director C.E.T.O.C.

Endoscopic UltraSound (EUS) Endoscopic Mucosal Resection (EMR) Moishe Liberman Director C.E.T.O.C. Endoscopic UltraSound (EUS) Endoscopic Mucosal Resection (EMR) Moishe Liberman Director C.E.T.O.C. Division of Thoracic Surgery Centre Hospitalier de l Université de Montréal Research Grants: Disclosures

More information

Barrett esophagus. Bible class Inselspital

Barrett esophagus. Bible class Inselspital Barrett esophagus Bible class Inselspital 2015.08.10 Guidelines Definition? BSG: ACG: Definition? BSG: ACG: What are the arguments for and against IM as prerequisite for the Dg? What are the arguments

More information

Everything Esophagus: Barrett s Esophagus. Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina

Everything Esophagus: Barrett s Esophagus. Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Everything Esophagus: Barrett s Esophagus Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina The Most Important Thing Stayed the Same Adenocarcinoma A

More information

7/20/2017. Esophageal Cancer: A Less Common But Deadly Cancer. Objectives. Disclosure Statement NYNPA Conference October Saratoga New York

7/20/2017. Esophageal Cancer: A Less Common But Deadly Cancer. Objectives. Disclosure Statement NYNPA Conference October Saratoga New York Esophageal Cancer: A Less Common But Deadly Cancer 2017 NYNPA Conference October 18-22 Saratoga New York Mary McGreal DNP, RN, ANP-C, CCRN, CMC, Adjunct Professor at Stony Brook University School of Nursing

More information

Endoscopic Management of Barrett s Esophagus

Endoscopic Management of Barrett s Esophagus Endoscopic Management of Barrett s Esophagus Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center Barrett s Esophagus Consequence of chronic GERD Mean

More information

Editorial: Advanced endoscopic therapeutics in Barrett s neoplasia; where are we now and where are we heading?

Editorial: Advanced endoscopic therapeutics in Barrett s neoplasia; where are we now and where are we heading? Editorial: Advanced endoscopic therapeutics in Barrett s neoplasia; where are we now and where are we heading? Dr. Gaius Longcroft-Wheaton MB,BS, MD, MRCP(UK), MRCP(Gastro) Consultant gastroenterologist

More information

Esophageal Cancer. Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care. David Demos MD Thoracic Surgery Aurora Cancer Care

Esophageal Cancer. Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care. David Demos MD Thoracic Surgery Aurora Cancer Care Esophageal Cancer Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care David Demos MD Thoracic Surgery Aurora Cancer Care No Disclosures Learning Objectives Review the classification scheme

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83 Oesophago-gastric cancer: assessment and management in adults NICE guideline Published: 24 January 18 nice.org.uk/guidance/ng83 NICE 18. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Expandable stents in digestive pathology present use in an emergency hospital

Expandable stents in digestive pathology present use in an emergency hospital ORIGINAL ARTICLES Article received on November30, 2015 and accepted for publishing on December15, 2015. Expandable stents in digestive pathology present use in an emergency hospital Mădălina Ilie 1, Vasile

More information

ESD for EGC with undifferentiated histology

ESD for EGC with undifferentiated histology ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>

More information

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux. Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately

More information

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Treatment Strategy for Non-curative Resection of Early Gastric Cancer Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Classic EMR/ESD data analysis style Endoscopic resection

More information

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ

Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ Barrett Esophagus - RadioFrequency Ablation (BE-RFA) - Project manual + FAQ Table of contents 1 General project information...3 1.1 Inclusion criteria...3 1.2 Registration time points...3 1.3 Project variable

More information

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery. Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This

More information

Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012

Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012 Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012 Case Presentation 60yr old AAF with PMH of CAD s/p PCI 1983, CVA, GERD, HTN presented with retrosternal chest pain on 06/12 Associated dysphagia

More information

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus Br J Surg 38 oct. 1950 Definition of Barrett's esophagus A change in the esophageal epithelium of any length that can be recognized

More information

Esophageal Cancer. What is esophageal cancer?

Esophageal Cancer. What is esophageal cancer? Scan for mobile link. Esophageal Cancer Esophageal cancer occurs when cancer cells develop in the esophagus. The two main types are squamous cell carcinoma and adenocarcinoma. Esophageal cancer may not

More information

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd ESOPHAGEAL CANCER AND GERD Prof Salman Guraya FRCS, Masters MedEd Learning objectives Esophagus anatomy and physiology Esophageal cancer Causes, presentations of esophageal cancer Diagnosis and management

More information

Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic management of Barrett s esophagus with dysplasia

Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic management of Barrett s esophagus with dysplasia UvA-DARE (Digital Academic Repository) Endoscopic management of Barrett s esophagus with dysplasia Phoa, Nadine Link to publication Citation for published version (APA): Phoa, K. Y. N. (2014). Endoscopic

More information

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False Quiz 1 1. Which of the following are risk factors for esophagus cancer. a. Obesity b. Gastroesophageal reflux c. Smoking and Alcohol d. All of the above 2. Adenocarcinoma of the distal stomach has been

More information

Sreeni Jonnalagadda, MD., FASGE Professor of Medicine, UMKC Director of Interventional Endoscopy Saint Luke s Hospital, Kansas City

Sreeni Jonnalagadda, MD., FASGE Professor of Medicine, UMKC Director of Interventional Endoscopy Saint Luke s Hospital, Kansas City Sreeni Jonnalagadda, MD., FASGE Professor of Medicine, UMKC Director of Interventional Endoscopy Saint Luke s Hospital, Kansas City Peptic stricture Shtki Schatzki s ring Esophageal cancer Radiation therapy

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation. See specific types, e.g., Thermal ablation Achalasia, 53 75 described, 53 features of, 53 management of past options, 54 POEM

More information

Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD

Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD Surgical Therapy of Gastric Cancer CLINICAL QUESTIONS 1. How much of the stomach should be removed? 2. How many lymph

More information

Evaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia

Evaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia ...PRESENTATIONS... Evaluating Treatments of Barrett s Esophagus That Shows High-Grade Dysplasia Based on a presentation by Bergein F. Overholt, MD Presentation Summary Thermal ablation and surgery are

More information

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds ESOPHAGEAL CANCER Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds ESOPHAGEAL CANCER I. EPIDEMIOLOGY INCIDENCE, DIAGNOSIS & STAGING II. TREATMENT OPTIONS Current role of induction therapies

More information

How to remove BE cancer: EMR or ESD? Expected outcome

How to remove BE cancer: EMR or ESD? Expected outcome How to remove BE cancer: EMR or ESD? Expected outcome Presented by Horst Neuhaus Institution Dpt. of Gastroenterology Evangelisches Krankenhaus Düsseldorf, Germany Indications for endoscopic resection

More information

Philip Chiu Associate Professor Department of Surgery, Prince of Wales Hospital The Chinese University of Hong Kong

Philip Chiu Associate Professor Department of Surgery, Prince of Wales Hospital The Chinese University of Hong Kong Application of Chromoendoscopy, NBI and AFI in Esophagus why, who, and how? Philip Chiu Associate Professor Department of Surgery, Prince of Wales Hospital The Chinese University of Hong Kong Cancer of

More information

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015 GERD: Who and When to Treat Eugenio J Hernandez, MD Gastrohealth, PL Assistant Professor of Clinical Medicine, FIU Herbert Wertheim School of Medicine Speaker disclosure I do not have any relevant commercial

More information

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus Endoscopic Radiofrequency Ablation or Cryoablation for Barrett s Esophagus Policy Number: 2.01.80 Last Review: 6/2018 Origination: 6/2012 Next Review: 6/2019 Policy Blue Cross and Blue Shield of Kansas

More information

Is a Metallic Stent Useful for Non Resectable Esophageal Cancer?

Is a Metallic Stent Useful for Non Resectable Esophageal Cancer? Original Article Is a Metallic Stent Useful for Non Resectable Esophageal Cancer? Shinsuke Wada, MD, 1 Tsuyoshi Noguchi, MD, 1 Shinsuke Takeno, MD, 1 Hatsuo Moriyama, MD, 1 Tsuyoshi Hashimoto, MD, 1 Yuzo

More information

Endoscopic Submucosal Dissection ESD

Endoscopic Submucosal Dissection ESD Endoscopic Submucosal Dissection ESD Peter Draganov MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida Gastrointestinal Cancer Lesion that Can be Treated

More information

Hiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery

Hiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery Hiatal Hernias and Barrett s esophagus Dr Sajida Ahad Mercy General Surgery Objectives Identify the use of different diagnostic modalities for hiatal hernias List the different types of hiatal hernias

More information

What s New in the Management of Esophageal Disease

What s New in the Management of Esophageal Disease What s New in the Management of Esophageal Disease Philip O. Katz, MD Chairman, Division of Gastroenterology Einstein Medical Center Philadelphia Clinical Professor of Medicine Jefferson Medical College

More information

Endoscopic Palliation of Malignant Dysphagia

Endoscopic Palliation of Malignant Dysphagia Endoscopic Palliation of Malignant Dysphagia 1. Scope of the guideline This guidance has been produced to support endoscopic palliation of malignant dysphagia from oesophageal cancer. 2. Guideline background

More information

How to stage early BE cancer - EUS or endoscopic removal?

How to stage early BE cancer - EUS or endoscopic removal? How to stage early BE cancer - EUS or endoscopic removal? Presented by Bas Weusten Institution St. Antonius Hospital, Nieuwegein Academic Medical Center, Amsterdam case 56 y old female patient Lung transplant

More information

Douglas G. Adler MD. ACG Regional Postgraduate Course - Nashville, TN Copyright 2013 American College of Gastroenterology

Douglas G. Adler MD. ACG Regional Postgraduate Course - Nashville, TN Copyright 2013 American College of Gastroenterology Enteral Stents 2013: State of the Art Douglas G. Adler MD Associate Professor of Medicine Director of Therapeutic Endoscopy University of Utah School of Medicine Huntsman Cancer Center Esophageal Stents

More information

EMR, ESD and Beyond. Peter Draganov MD. Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida

EMR, ESD and Beyond. Peter Draganov MD. Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida EMR, ESD and Beyond Peter Draganov MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Florida Gastrointestinal Cancer Lesion that Can be Treated by Endoscopy

More information

Radiofrequency Ablation: Stepwise circumferential and focal RFA of Barrett s s esophagus using the HALO System

Radiofrequency Ablation: Stepwise circumferential and focal RFA of Barrett s s esophagus using the HALO System Radiofrequency Ablation: Stepwise circumferential and focal RFA of Barrett s s esophagus using the HALO System Used abbreviations BE: Barrett s esophagus EC: Early cancer ER: Endoscopic resection HGD:

More information

ESPEN Congress Brussels Stenting of the esophagus and small bowel. Jean-Marc Dumonceau

ESPEN Congress Brussels Stenting of the esophagus and small bowel. Jean-Marc Dumonceau ESPEN Congress Brussels 2005 Stenting of the esophagus and small bowel Jean-Marc Dumonceau Stenting of the esophagus and small bowel Jean-Marc Dumonceau, Div. of Gastroenterology Geneva, Switzerland Indication:

More information

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus

Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus Endoscopic Radiofrequency Ablation or Cryoablation for Barrett Esophagus Policy Number: Original Effective Date: MM.02.005 09/01/2010 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration

More information

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006 Minimally Invasive Esophagectomy- Valuable Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006 Overview Esophageal carcinoma What is minimally invasive esophagectomy (MIE)?

More information

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology: Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 A 74 year old male with a history of GERD presents complaining of dysphagia. An esophagogastroduodenoscopy

More information

Esophageal Cancer: A Multimodality Approach to Detection and Staging

Esophageal Cancer: A Multimodality Approach to Detection and Staging Esophageal Cancer: A Multimodality Approach to Detection and Staging, MBA Topic: Esophageal Cancer Imaging: A multimodality approach Conference: Society of Thoracic Imaging Location: Date/Time: March 14,

More information

Endoscopic Treatment of Luminal Perforations and Leaks

Endoscopic Treatment of Luminal Perforations and Leaks Endoscopic Treatment of Luminal Perforations and Leaks Ali A. Siddiqui, MD Professor of Medicine Director of Interventional Endoscopy Jefferson Medical College Philadelphia, PA When Do You Suspect a Luminal

More information

9/18/2015. Disclosures. Objectives. Dysphagia Sherri Ekobena PA-C. I have no relevant financial interests to disclose I have no conflicts of interest

9/18/2015. Disclosures. Objectives. Dysphagia Sherri Ekobena PA-C. I have no relevant financial interests to disclose I have no conflicts of interest Dysphagia Sherri Ekobena PA-C Disclosures I have no relevant financial interests to disclose I have no conflicts of interest Objectives Define what dysphagia is Define types of dysphagia Define studies

More information

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic cancer Section AA Cancer Centre Referrals In the absence of metastatic

More information

Mediastinal Staging. Samer Kanaan, M.D.

Mediastinal Staging. Samer Kanaan, M.D. Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor

More information

Case 1- B.N. 66 yr old F with PMHx of breast cancer s/ p mastectomy, HTN, DM presented with dysphagia to solids and liquids.

Case 1- B.N. 66 yr old F with PMHx of breast cancer s/ p mastectomy, HTN, DM presented with dysphagia to solids and liquids. Case 1- B.N 66 yr old F with PMHx of breast cancer s/ p mastectomy, HTN, DM presented with dysphagia to solids and liquids. Reports retching to clear esophagus. Case 1- B.N EGD: Stricture in the distal

More information

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department

More information

Imaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD

Imaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD Imaging techniques in the diagnosis, staging and follow up of GI cancers Moderators: Banke Agarwal, MD and Paul Schultz, MD Panelists Axel Grothey, MD Professor of Oncology Division of Medical Oncology

More information

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE PROFESSOR OF SURGERY & DIRECTOR, PROFESSIONAL DEVELOPMENT CENTRE J I N N A H S I N D H M E D I C A L U N I V E R S I T Y faisal.siddiqui@jsmu.edu.pk

More information

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Dr Ian Chau Consultant Medical Oncologist Women's cancers Breast cancer introduction 3 What profession are you in?

More information

Accepted Manuscript. CGH Editorial: Sound the Alarm for Barrett s Screening! Tarek Sawas, M.D., M.P.H., David A. Katzka, M.D

Accepted Manuscript. CGH Editorial: Sound the Alarm for Barrett s Screening! Tarek Sawas, M.D., M.P.H., David A. Katzka, M.D Accepted Manuscript CGH Editorial: Sound the Alarm for Barrett s Screening! Tarek Sawas, M.D., M.P.H., David A. Katzka, M.D PII: S1542-3565(18)31093-0 DOI: 10.1016/j.cgh.2018.10.010 Reference: YJCGH 56132

More information

Barrett's Esophagus: Sorting Out the Controversy

Barrett's Esophagus: Sorting Out the Controversy Barrett's Esophagus: Sorting Out the Controversy Learning Objectives 1. Identify the challenges in screening for Barrett s esophagus 2. Demonstrate comprehension of the risk of progression of Barrett s

More information

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma

American Journal of Gastroenterology. Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma Volumetric Laser Endomicroscopy Detects Subsquamous Barrett s Adenocarcinoma Journal: Manuscript ID: AJG-13-1412.R1 Manuscript Type: Letter to the Editor Keywords: Barrett-s esophagus, Esophagus, Endoscopy

More information

Approaches to Surgical Treatment of Gastric Cancer. Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service

Approaches to Surgical Treatment of Gastric Cancer. Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service Approaches to Surgical Treatment of Gastric Cancer Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service Disclosures I do not have anything to disclose Outline Background Diagnosis Histology Staging Surgery

More information

Barrett s Esophagus. Radiofrequency Ablation with the HALO Technology A Reference Book

Barrett s Esophagus. Radiofrequency Ablation with the HALO Technology A Reference Book Radiofrequency Ablation with the HALO Technology A Reference Book 540 Oakmead Parkway, Sunnyvale, CA 94085 What is Barrett s esophagus? Barrett s esophagus is a change that occurs within the cellular lining

More information

The role of esophageal brachytherapy

The role of esophageal brachytherapy Esophageal cancer is combination with surgery (stents) or EBRT a better solution? Razvan Galalae, MD, PhD Associate Professor, Medical Faculty, Christian Albrecht University Kiel, Germany, and Head of

More information

Principles of diagnosis, work-up and therapy The Gastroenterologist s role

Principles of diagnosis, work-up and therapy The Gastroenterologist s role Principles of diagnosis, work-up and therapy The Gastroenterologist s role Dr. Christos G. Toumpanakis MD PhD FRCP Consultant in Gastroenterology/Neuroendocrine Tumours Hon. Senior Lecturer University

More information

The first stents designed for use in the biliary tree and

The first stents designed for use in the biliary tree and Imaging and Advanced Technology Michael B. Wallace, Section Editor Expandable Gastrointestinal Stents TODD H. BARON Department of Medicine, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester,

More information

Current status of gastric ESD in Korea. Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea

Current status of gastric ESD in Korea. Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea Current status of gastric ESD in Korea Jun Haeng Lee. Department of Medicine Sungkyunkwanuniversity School of Medicie, Seoul, Korea Contents Brief history of gastric ESD in Korea ESD/EMR for gastric adenoma

More information

Changes to the diagnosis and management of Barrett s Oesophagus

Changes to the diagnosis and management of Barrett s Oesophagus Changes to the diagnosis and management of Barrett s Oesophagus A review of the new BSG and NICE guidelines and best practice Anjan Dhar DM, MD, FRCPE, AGAF, MBBS (Hons.), Cert. Med. Ed Senior Lecturer

More information

Стенты «Ella-cs» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts»

Стенты «Ella-cs» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts» A. Esophageal Stenting and related topics 1 AMJG 2009; 104:1329 1330 Letters to Editor Early Tracheal Stenosis Post Esophageal Stent

More information

The following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only.

The following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only. The following slides are provided as presented by the author during the live educa7onal ac7vity and are intended for reference purposes only. If you have any ques7ons, please contact Imedex via email at:

More information

Barrett s Esophagus: State of the Art. Food Getting Stuck

Barrett s Esophagus: State of the Art. Food Getting Stuck Barrett s Esophagus: State of the Art Nicholas J. Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina SOM Food Getting Stuck 73-year-old retired Wilmington police

More information

The Itracacies of Staging Patients with Suspected Lung Cancer

The Itracacies of Staging Patients with Suspected Lung Cancer The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung

More information

Meta analysis in Rectal Cancer

Meta analysis in Rectal Cancer Meta analysis in Rectal Cancer Dr. Monica Irukulla Professor and Head Department of Radiation Oncology Nizam s Institute of Medical Sciences hyderabad Areas of meta analysis in rectal cancers Epidemiology

More information

Early View Article: Online published version of an accepted article before publication in the final form.

Early View Article: Online published version of an accepted article before publication in the final form. : Online published version of an accepted article before publication in the final form. Journal Name: Journal of Case Reports and Images in Surgery Type of Article: Case Report Title: What is the treatment

More information

Therapeutic Bronchoscopy Etiology - Benign Stenosis Post - intubation Trauma Post - operative Inflammatory Idiopathic

Therapeutic Bronchoscopy Etiology - Benign Stenosis Post - intubation Trauma Post - operative Inflammatory Idiopathic Endobronchial Palliation of Airway Disease Douglas E. Wood, MD Professor and Chief Division of Cardiothoracic Surgery Vice-Chair, Department of Surgery Endowed Chair in Lung Cancer Research University

More information

WHO BENEFITS FROM ADJUVANT CHEMOTHERAPY RADIATION CHEMORADIATION? Dr. Paul Gardiner April 23, 2001 Discipline of Surgery Grand Rounds

WHO BENEFITS FROM ADJUVANT CHEMOTHERAPY RADIATION CHEMORADIATION? Dr. Paul Gardiner April 23, 2001 Discipline of Surgery Grand Rounds WHO BENEFITS FROM ADJUVANT CHEMOTHERAPY RADIATION CHEMORADIATION? Dr. Paul Gardiner April 23, 2001 Discipline of Surgery Grand Rounds LUNG Dr. Greenland ESOPHAGUS Dr. Gardiner ESOPHAGEAL CANCER 1200 new

More information

Owen Dickinson. Consultant in Endoscopy & Interventional Radiology. Upper GI Stenting. Rotherham Foundation Trust

Owen Dickinson. Consultant in Endoscopy & Interventional Radiology. Upper GI Stenting. Rotherham Foundation Trust Owen Dickinson Consultant in Endoscopy & Interventional Radiology Upper GI Stenting Rotherham Foundation Trust Owen Dickinson Consultant in Endoscopy & Interventional Radiology Rotherham Foundation Trust

More information

Barrett s Oesophagus Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.

Barrett s Oesophagus Information Leaflet THE DIGESTIVE SYSTEM.   gutscharity.org. THE DIGESTIVE SYSTEM http://healthfavo.com/digestive-system-for-kids.html This factsheet is about Barrett s Oesophagus Barrett s Oesophagus is the term used for a pre-cancerous condition where the normal

More information

Medicinae Doctoris. One university. Many futures.

Medicinae Doctoris. One university. Many futures. Medicinae Doctoris The Before and The After: Can chemotherapy revise the trajectory of gastric and esophageal cancers? Dr. David Dawe MD, FRCPC Medical Oncologist Assistant Professor Disclosures None All

More information